Ignite Creation Date:
2024-05-06 @ 7:45 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06120907
Status:
RECRUITING
Last Update Posted:
2023-11-13
First Post:
2023-11-01
Brief Title:
Swiss Itch Registry
Sponsor:
University Hospital Basel Switzerland
Organization:
University Hospital Basel Switzerland
Study Overview
Official Title:
Swiss Itch Registry SWITCHR - A Prospective Registry to Collect Data of Patients With Chronic Pruritus
Status:
RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SWITCHR
Brief Summary:
This project is to develop a national registry for CP patients Patients admitted to this registry will be examined and documented with PROs physician-based assessments blood tests 3D photodocumentation and if indicated by skin biopsies neurophysiological testing and radiological imaging at defined timepoints The data collection will allow deepened insights into patient needs different mechanisms and courses of pruritic conditions treatment outcomes and treatment-related safety issues In addition the collection of clinical biological and image-based data may be used for retrospective analyses
Detailed Description:
Pruritus synonymous itch is the commonest skin-related symptom caused by numerous dermatological and non-dermatological conditions Chronic pruritus CP defined by a duration of 6 weeks is associated with significantly impaired quality of life and high socio-economic burden At present a data registry to monitor and compare clinical presentation treatment outcomes and safety issues of these patients is lacking in Switzerland The implementation of the SWITCHR could help to i improve medical care of CP patients ii allow standardised comparison of different pruritic conditions as well as national data with international CP populations and iii raise the awareness for CP in general practitioners health care institutions national public health authorities and pharmaceutical companies within Switzerland
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None